Recent News

ASCO 2019: Final Results of KRISTINE Trial of Neoadjuvant Regimens in HER2-Positive Breast Cancer

New Trastuzumab Biosimilar Approved by the FDA

ASCO 2019: Can Clinical Risk Stratification Predict Chemotherapy Benefit in Early Breast Cancer?

Targeting Mitochondrial Metabolism in Triple-Negative Breast Cancer

ACP Issues New Guidance Statement for Breast Cancer Screening in Average-Risk Women

ASCO 2019: CDK4/6 Inhibitor Plus Endocrine Therapy Improves Overall Survival in Advanced Breast Cancer

Retrospective Update on Nipple-Sparing Mastectomy

U.S. and Canadian Home Recovery Programs After Mastectomy

FDA Approves Alpelisib Combination Therapy for Advanced Breast Cancer

Breast Cancer Treatment Outcomes in Young Women

Effect of Chemotherapy Scheduling on Quality of Life in Advanced Breast Cancer

ARRS 2019: BI-RADS 3 Lesions Identified on High-Risk Screening Breast MRI

ASCO 2019: Can a Low-Fat Diet Reduce Breast Cancer Mortality?

Leronlimab Granted Fast Track Designation in Metastatic Triple-Negative Breast Cancer

ESMO Breast 2019: Global Survey of HER2 Testing Shows Room for Improvement

ESMO Breast 2019: Intermittent vs. Continuous Chemotherapy in HER2-Negative Breast Cancer

ASBrS 2019: Some Women With HER2-Positive Breast Cancer May Not Need Surgery

Ado-Trastuzumab Emtansine Granted FDA Approval in HER2-Positive Early Breast Cancer

ESMO Breast 2019: De-escalation Strategy for Women With HER2-Positive Metastatic Breast Cancer

ESTRO 2019: 10-Year Follow-up of Whole-Breast Irradiation in Low-Risk Breast Cancer

Breast Cancer’s Genetic Relationship to Other Cancers

Brain Metastases and Estrogen: Is There a Link in Triple-Negative Breast Cancer?

Canada Halts Sales of Cancer-Linked Breast Implants

INT230-6 Granted Fast Track Designation in Metastatic Triple-Negative Breast Cancer

AACR 2019: Primary Tumor Surgery for Advanced HER2-Positive Breast Cancer

AACR 2019: Predicting Breast Cancer Survival With Estrogen Byproducts

HOPA 2019: Does Receptor Expression Affect Efficacy of Talazoparib in Advanced Breast Cancer?

Is There a Link Between Age Acceleration and Breast Cancer Risk?

FDA Extends Indication of Palbociclib Combination to Men With Breast Cancer

Novel Antibody Drug-Conjugate in Metastatic Triple-Negative Breast Cancer

Study Finds Shifting Trend in Breast Cancer Risk in Asian American Women

Predicting Outcomes With Lung Immune Prognostic Index

ASCO-SITC 2019: HER2-Targeted Vaccine Plus Trastuzumab in Breast Cancer

Trastuzumab Biosimilar for HER2-Overexpressing Breast Cancer Approved by the FDA

FDA Grants Accelerated Approval to Atezolizumab Combination in Triple-Negative Breast Cancer

FDA Approves New Formulation of Trastuzumab for Subcutaneous Use in Some Breast Cancers

2019 ASCO-SITC: Neoadjuvant Chemotherapy and the Immunologic Landscape in Breast Cancer

Targeting Chemotherapy-Resistant Breast Cancer

Can Oolong Tea Inhibit Growth of Breast Cancer?

Reducing Risk for Invasive Breast Cancer With Low-Dose Tamoxifen

Comparing Breast Irradiation Regimens in Preventing Local Recurrence

Impact of Pathologic Complete Response on Breast Cancer Recurrence and Mortality

Racial Disparities in Breast Cancer Prevention: Focus on Complexity of Gathering Information

FDA Approves Trastuzumab Biosimilar for Treatment of Advanced Breast Cancer

Predictive Biomarker in Metastatic Triple-Negative Breast Cancer

Does Oxybutynin Reduce Hot Flashes in Breast Cancer Survivors?

SOLAR-1: Predicting Response to Alpelisib in PIK3CA-Mutant Breast Cancer

Can Cryoablation ‘Freeze Out’ Low-Risk Breast Cancers?

Shedding Light on Resistance to PARP Inhibitors in Patients With Breast Cancer

Conventional Whole-Breast vs. Partial-Breast Irradiation in Controlling Tumor Recurrence

Should Some Women Younger Than Age 30 Undergo Mammography?